Negocie JnJ JNJ

Venda
 Comprar

Gráfico JnJ ao vivo

5m 15m 30m 1h 4h 1d 1w

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

JnJ news

Tommy Yap 2025 Jul 12, 21:00

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

Forex Indices
Tommy Yap 2025 Apr 12, 16:00

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Forex Indices
ECB set to cut rates for the third time this year
Neil Wilson 2024 Oct 10, 16:00

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Forex Indices
US earnings season kicks off, ECB expected to hold rates steady
Neil Wilson 2024 Jul 11, 21:00

Week ahead: US earnings season kicks off, ECB hold expected

Forex Indices
Oil steady, gold bearish trend
Neil Wilson 2024 Jan 22, 08:15

Europe Tries to Ride on US Coat-tails

Stocks Forex Commodities Indices

Últimas notícias

Mostrar mais
Sophia Claire 2025 Aug 28, 01:20

Denmark Summons US Envoy Over Greenland Influence Concerns

Noah Lee 2025 Aug 28, 01:20

US Companies' Stock Buyback Surge: Nvidia Joins the Trillion-Dollar Trend

Ava Grace 2025 Aug 28, 00:20

Trump's White House Meeting: Post-War Gaza Plans & Hamas Negotiation Efforts

Noah Lee 2025 Aug 28, 00:20

E3 Considers Snapback Sanctions on Iran: A Diplomatic Tightrope Walk

Emma Rose 2025 Aug 27, 23:20

Nvidia's Q2 Earnings: Growth Slows Amid China Concerns and Supply Constraints

Ghko B 2025 Aug 27, 16:00

Nvidia's Competitors News: China AI Chipmaker Cambricon Sees Revenue Surge

Stocks
Sophia Claire 2025 Aug 27, 13:20

EU Eyes Tariff Removal on US Goods Amid Trade Deal Push

Noah Lee 2025 Aug 27, 09:20

Asian Markets Ease Gold ETF Restrictions Amid Geopolitical Uncertainty

Info

Spread

1.07

Spread (%)

0.6075 %

Alavancagem

1:2

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Quinta-feira

13:31 - 19:59

Segunda-feira

13:31-19:59

Terça-feira

13:31-19:59

Quarta-feira

13:31-19:59

Sexta-feira

13:31-19:59

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

425047949312

Ações em circulação

2408339968

Data dos rendimentos (Próxima)

2001-06-13

Rendim Divid

2025-09-09

Data Ex-Dividendos

2025-08-26

Taxa anual futura de dividendos

5.2

Rendimento anual futuro de dividendos

0.0291

EPS

9.35

Saiba mais sobre este instrumento

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):

Negociar agora

Negociar agora

Negociar agora

Negociar agora
Instrumentos relacionados

latest_education_articles

Mostrar mais
Trustpilot